Experimental modulation of Interleukin 1 shows its key role in chronic kidney disease progression and anemia

Inflammation in chronic kidney disease (CKD) is mostly due to activation of the innate immune system, in which Interleukin-1 (IL-1) is a key player. Anemia of CKD may also be due to erythropoietin (EPO) resistance, clinically associated with inflammation. IL-1 receptor antagonist knockout (RaKO) mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandach, Inbar, Segev, Yael, Landau, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973507/
https://www.ncbi.nlm.nih.gov/pubmed/33737665
http://dx.doi.org/10.1038/s41598-021-85778-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973507/
https://www.ncbi.nlm.nih.gov/pubmed/33737665
http://dx.doi.org/10.1038/s41598-021-85778-2

Ejemplares similares